1, 2, 4-oxadiazole derivatives as hppar alpha agonists

Details for Australian Patent Application No. 2002220902 (hide)

Owner Glaxo Group Limited

Inventors Liu, Kevin Guangcheng; Gellibert, Francoise Jeanne

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002220902

PCT Pub. Number WO02/46174

Priority 0029974 08.12.00 GB

Filing date 6 December 2001

Wipo publication date 18 June 2002

Acceptance publication date 2 June 2005

International Classifications

C07D 271/06 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 003/06 Drugs for disorders of the metabolism

A61K 031/4245 - Oxadiazoles

Event Publications

2 June 2005 Application Accepted

  Published as AU-B-2002220902

29 September 2005 Standard Patent Sealed

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002220903

2002220901